Candel Therapeutics

OverviewSuggest Edit

Candel Therapeutics is a biotechnology company developing the Gene Mediated Cytotoxic Immunotherapy (GMCI™) and the oncolytic rQNestin34.5 platforms for the treatment of solid tumors. The Company's lead programs include two randomized studies in prostate cancer, including a Phase 3 under an FDA approved special protocol assessment, as well as ongoing clinical programs in glioma, lung and pancreatic cancer.

TypePrivate
HQArlington, US
Websitecandeltx.com

Locations

Candel Therapeutics is headquartered in
Arlington, United States

Location Map

Candel Therapeutics Office Locations

Candel Therapeutics has offices in Arlington and Needham
Arlington, US (HQ)
Rosslyn
Needham, US
117 Kendrick St #450
Show all (2)

Candel Therapeutics Financials and Metrics

Summary Metrics

Candel Therapeutics total Funding

$51.2 m

Candel Therapeutics latest funding size

$22.50 m

Time since last funding

a year ago

Candel Therapeutics investors

Candel Therapeutics's latest funding round in April 2019 was reported to be $22.5 m. In total, Candel Therapeutics has raised $51.2 m
Show all financial metrics

Candel Therapeutics Online and Social Media Presence

Embed Graph

Candel Therapeutics Frequently Asked Questions

  • Who are Candel Therapeutics competitors?

    Competitors of Candel Therapeutics include Mendel.ai, Lipella Pharmaceuticals and Immundnz.

  • Where is Candel Therapeutics headquarters?

    Candel Therapeutics headquarters is located at Rosslyn, Arlington.

  • Where are Candel Therapeutics offices?

    Candel Therapeutics has offices in Arlington and Needham.

  • How many offices does Candel Therapeutics have?

    Candel Therapeutics has 2 offices.